Status:

TERMINATED

Treatment With Autologous Skeletal Myoblasts

Lead Sponsor:

Clinica Universidad de Navarra, Universidad de Navarra

Collaborating Sponsors:

Fina Biotech

Conditions:

Old Myocardial Infarction

Eligibility:

All Genders

30-80 years

Phase:

PHASE2

Brief Summary

The purpose of this study is to determine the benefit of autologous skeletal myoblast injection in patients with old myocardial infarction and ventricular dysfunction versus conventional revascularisa...

Detailed Description

Ischaemic heart disease is one of the main causes of mortality and morbidity. In particular, myocardial infarction (MI) is of special significance, as the heart muscle cannot regenerate so a region's ...

Eligibility Criteria

Inclusion

  • Patients with a diagnosis of coronary disease obtained by coronary angiography who require conventional aortocoronary bypass surgery.
  • History of myocardial infarction with evidence of regional akinesis (or dyskinesia) for more than 4 weeks and less than 10 years.
  • Ejection fraction from 25% to 45%.
  • Evidence of no regional viability by dobutamine echocardiography.
  • Aged from 30-80 years old.
  • Negative serology to HIV, HBV and HCV.
  • Patients without organ dysfunction.
  • Negative pregnancy test (women of childbearing age).
  • Informed consent granted.

Exclusion

  • History of myocardial infarction in the 4 weeks prior to the inclusion in the study.
  • Prior history of tachycardia or ventricular fibrillation (except in patients with DAI device).
  • History of cancer (except basocellular carcinoma) or prior treatment with chemotherapy.
  • The patient should not suffer from any concomitant severe and/or uncontrolled medical condition.
  • Patients who, due to their geographical, psychiatric or social status, have difficulties in meeting the conditions established in the protocol.
  • Pregnant or beast feeding women.

Key Trial Info

Start Date :

May 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2010

Estimated Enrollment :

3 Patients enrolled

Trial Details

Trial ID

NCT00975234

Start Date

May 1 2009

End Date

January 1 2010

Last Update

June 8 2012

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

Hospital Clínico Universitario de Santiago

Santiago de Compostela, Galicia, Spain, 15706

2

Hospital Gregorio Marañón

Madrid, Madrid, Spain, 28007

3

Hospital Clínico San Carlos

Madrid, Madrid, Spain, 28040

4

Clínica Universitaria de Navarra

Pamplona, Navarre, Spain, 31008